Germline mutations in BRCA1 and BRCA2, involved in HR and FA repair, increase the risk of developing breast and ovarian cancer 40-80% and 11-40%, respectively, in addition to other cancer types [5]. This evidence concerns the gene BRCA2 and ovarian cancer.